Vital signs: carbapenem-resistant Enterobacteriaceae
- PMID: 23466435
- PMCID: PMC4604788
Vital signs: carbapenem-resistant Enterobacteriaceae
Abstract
Background: Enterobacteriaceae are a family of bacteria that commonly cause infections in health-care settings as well as in the community. Among Enterobacteriaceae, resistance to broad-spectrum carbapenem antimicrobials has been uncommon. Over the past decade, however, carbapenem-resistant Enterobacteriaceae (CRE) have been recognized in health-care settings as a cause of difficult-to-treat infections associated with high mortality.
Methods: The percentage of acute-care hospitals reporting at least one CRE from health-care-associated infections (HAIs) in 2012 was estimated using data submitted to the National Healthcare Safety Network (NHSN) in 2012. The proportion of Enterobacteriaceae infections that were CRE was calculated using two surveillance systems: 1) the National Nosocomial Infection Surveillance system (NNIS) and NHSN (for 2001 and 2011, respectively) and 2) the Surveillance Network-USA (TSN) (for 2001 and 2010). Characteristics of CRE culture-positive episodes were determined using data collected as part of a population-based CRE surveillance project conducted by the Emerging Infections Program (EIP) in three states.
Results: In 2012, 4.6% of acute-care hospitals reported at least one CRE HAI (short-stay hospitals, 3.9%; long-term acute-care hospitals, 17.8%). The proportion of Enterobacteriaceae that were CRE increased from 1.2% in 2001 to 4.2% in 2011 in NNIS/NHSN and from 0% in 2001 to 1.4% in 2010 in TSN; most of the increase was observed in Klebsiella species (from 1.6% to 10.4% in NNIS/NHSN). In the EIP surveillance, 92% of CRE episodes occurred in patients with substantial health-care exposures.
Conclusions: Carbapenem resistance among common Enterobacteriaceae has increased over the past decade; most CRE are associated with health-care exposures.
Implications for public health: Interventions exist that could slow the dissemination of CRE. Health departments are well positioned to play a leading role in prevention efforts by assisting with surveillance, situational awareness, and coordinating prevention efforts.
Similar articles
-
Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.Antimicrob Resist Infect Control. 2020 Jan 3;9(1):2. doi: 10.1186/s13756-019-0639-7. eCollection 2020. Antimicrob Resist Infect Control. 2020. PMID: 31911830 Free PMC article.
-
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.PLoS One. 2015 Sep 25;10(9):e0139116. doi: 10.1371/journal.pone.0139116. eCollection 2015. PLoS One. 2015. PMID: 26407326 Free PMC article.
-
Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.Infect Control Hosp Epidemiol. 2014 Apr;35(4):342-9. doi: 10.1086/675611. Infect Control Hosp Epidemiol. 2014. PMID: 24602937
-
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.Clin Infect Dis. 2011 Jul 1;53(1):60-7. doi: 10.1093/cid/cir202. Clin Infect Dis. 2011. PMID: 21653305 Review.
-
An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4. Clin Infect Dis. 2014. PMID: 24304707 Review.
Cited by
-
A call to action: the SHEA research agenda to combat healthcare-associated infections.Infect Control Hosp Epidemiol. 2024 Oct 25;45(9):1-18. doi: 10.1017/ice.2024.125. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39448369 Free PMC article. No abstract available.
-
Diagnosing and Managing Urinary Tract Infections in Kidney Transplant Recipients.Infect Dis Clin North Am. 2024 Jun;38(2):361-380. doi: 10.1016/j.idc.2024.03.008. Infect Dis Clin North Am. 2024. PMID: 38729666 Review.
-
Assessing bacterial prevalence and resistance in paediatric meningitis: safeguarding the central nervous system.Ann Med Surg (Lond). 2024 Mar 12;86(5):2671-2676. doi: 10.1097/MS9.0000000000001953. eCollection 2024 May. Ann Med Surg (Lond). 2024. PMID: 38694313 Free PMC article.
-
Detection of blaKPC gene among carbapenemase producing Klebsiella pneumoniae isolated from different clinical specimens at tertiary care hospital of Nepal.BMC Microbiol. 2024 Apr 25;24(1):144. doi: 10.1186/s12866-024-03301-9. BMC Microbiol. 2024. PMID: 38664608 Free PMC article.
-
Deciphering the gastrointestinal carriage of Klebsiella pneumoniae.Infect Immun. 2024 Sep 10;92(9):e0048223. doi: 10.1128/iai.00482-23. Epub 2024 Apr 10. Infect Immun. 2024. PMID: 38597634 Free PMC article. Review.
References
-
- Donnenberg MS. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010. Enterobacteriaceae [Chapter 218] pp. 2815–34.
-
- Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34:1–14. - PubMed
-
- Gaynes RP, Culver DH. Resistance to imipenem among selected Gram-negative bacilli in the United States. Infect Control Hosp Epidemiol. 1992;13:10–4. - PubMed
-
- Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099–106. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous

